Page 477 - Book Hosokawa Nanoparticle Technology Handbook

6 DESIGN OF NANOPARTICLES FOR ORAL DELIVERY OF PEPTIDE DRUGS APPLICATIONS
References [24] D.N. Robinson, N.A. Peppas: Macromolecules, 35,
3668–3674 (2002).
[1] E. Allemann, J.C. Leroux and R. Gurny: Adv. Drug [25] F. Madsen, N.A. Peppas: Biomaterials, 20,
Del. Rev., 34, 171–189 (1998). 1701–1708 (1999).
[2] F. Delie: Adv. Drug Del. Rev., 34, 221–233 (1998). [26] M.T. Lugo, M. Garcia, R. Record and N.A. Peppas:
[3] T. Jung, W. Kamm, A. Breitenbach, E. Kaiserling, Biotechnol. Prog., 18, 612–616 (2002).
J.X. Xiao and T. Kissel: Eur. J. Pharm. Biopharm., 50, [27] H. Ichikawa, N.A. Peppas: J. Biomed. Mater. Res.,
147–160 (2000). 67A, 609–617 (2003).
[4] J. Kreuter: Int. J. Pharm., 331, 1–10 (2007). [28] H. Ichikawa, Y. Yamasaki and Y. Fukumori: in New
[5] C. Marriott, N.P. Gregory: Mucus physiology and Trend in Polymers for Oral and Parental Administration,
pathology in Bioadhesive Drug Delivery Systems, Eds. G. Barratt, D. Duchêne, F. Fattal, J.Y. Legendre,
Eds. V. Lenaerts, R. Gurny, CRC Press, Inc., Florida, De Sante, Paris, pp. 257–260 (2001).
p. 1 (1990). [29] S. Haruna, H. Ichikawa and Y. Fukumori: Proceedings
[6] X. Yang, J.R. Robinson: Bioadhesion in Mucosal Drug of the 2nd Asian particle technology symposium
Delivery in Biorelated Polymers and Gels, Ed. 2003, Malaysia, 277–284 (2003)
T. Okano, Academic Press, U.S.A., pp. 135–192 (1998). [30] S. Sakuma, M. Hayashi and M. Akashi: Adv. Drug
[7] R. Bansil, E. Stanley and T. LaMont: Annu. Rev. Del. Rev., 47, 21–37 (2001).
Physiol., 57, 635–657 (1995). [31] G.P. Carino, J.S. Jacob and E. Mathiowitz: J. Control.
[8] C.M. Lehr, F.G.J. Poelma, H.E. Junginger and Release, 65, 261–269 (2000).
J.J. Tukker: Int. J. Pharm., 70, 235–240 (1991). [32] Y. Kawashima, H. Yamamoto, H. Takeuchi, T. Hino
[9] S. Kerss, A. Allen and A. Garner: Clin. Sci., 63, and T. Niwa: Eur. J. Pharm. Biopharm., 45, 48 (1998).
187–195 (1982). [33] Y. Kawashima, H. Yamamoto, H. Takeuchi and
[10] D.A. Norris, P.J. Sinko: J. Appl. Polym. Sci., 63, Y. Kuno: Pharm. Dev. Tech., 5, 77–85 (2000).
1481–1492 (1997). [34] H.S. Yoo, T.G. Park: J. Pharm. Sci., 93, 488–495
[11] N.N. Sanders, S.C.D. Smedt and J. Demeester: (2004).
J. Pharm. Sci., 89, 835–849 (2000). [35] D. Attivi, P. Wehrle, N. Ubrich, C. Damge,
[12] H. Takeuchi, Y. Matsui, H. Sugihara, H. Yamamoto and M. Hoffman and P. Maincent, Drug Dev. Ind. Pharm.,
Y. Kawashima: Int. J. Pharm., 303, 160–170 (2005). 31, 179–189 (2005).
[13] P.U. Jani, G.W. Halbert, J. Langridge and A.T. Florence: [36] K. Yoncheva, E. Lizarraga and J.M. Irache: Eur.
J. Pharm. Pharmacol., 42, 821–826 (1990). J. Pharm. Sci., 24, 411–419 (2005).
[14] P.G. Jenkins, K.A. Howard, N.W. Blackhall, N.W. [37] J.S. Rodrigues, N.S. Santos-Magalhaes, L.C.B.B.
Thomas, S.S. Davis and D.T. O’Hagan: J. Control. Coelho, P. Couvreur, G. Ponchel and R. Gref:
Release, 29, 339–350 (1994). J. Control. Release, 92, 103–112 (2003).
[15] N. Zhang, Q.N. Ping, G.H. Huang and W.F. Xu: Int. [38] M. Simon, M. Wittmar, U. Bakowsky and T. Kissel:
J. Pharm., 294, 247–259 (2005). Bioconjug. Chem., 15, 841–849 (2004).
[16] Y. Aramaki, H. Tomizawa, T. Hara, K. Yachi, H. Kikuchi [39] I. Behrens, A.I.V. Pena, M.J. Alonso and T. Kissel:
and S. Tsuchiya: Pharm. Res., 10, 1228–1231 (2003). Pharm. Res., 19, 1185–1193 (2002).
[17] K. Iwanaga, S. Ono, K. Norioka, K. Morimoto, [40] Z. Ma, T.M. Lim and L.Y. Lim: Int. J. Pharm., 293,
M. Kakemi, S. Yamashita, M. Nango and N. Oku: Int. 271–280 (2005).
J. Pharm., 157, 73–80 (1997). [41] K. Cheng, L.Y. Lim: Drug Dev. Ind. Pharm., 30,
[18] H. Takeuchi, Y. Matsui, H. Yamamoto and 359–367 (2004).
Y. Kawashima: J. Control. Release, 86, 235–242 [42] Y.H. Lin, C.K. Chung, C.T. Chen, H.F. Liang, S.C.
(2003). Chen and H.W. Sung: Biomacromolecules, 6,
[19] C. Damge, C. Michel, M. Aprahamian and 1104–1112 (2005).
P. Couvreur: Diabetes, 37, 246–251 (1988). [43] J. Du, R. Sun, S. Zhang, L.F. Zhang, C.D. Xiong and
[20] D. Das, S. Lin: J. Pharm. Sci., 94, 1343–1353 (2005). Y.X. Peng: Biopolymers, 78, 1–8 (2005).
[21] H. Ichikawa, N.A. Peppas: in New Trend in Polymers [44] Z. Ma, L.Y. Lim: Pharm. Res., 20, 1812–1819 (2003).
for Oral and Parental Administration, Eds. G. Barratt, [45] O. Borges, G. Borchard, J.C. Verhoef, A. de Sousa and
D. Duchêne, F. Fattal, J.Y. Legendre, De Sante, Paris, H.E. Junginger: Int. J. Pharm., 299, 155–166 (2005).
pp. 261–264 (2001). [46] N. Venkatesan, J. Yoshimitsu, Y. Ito, N. Shibata and
[22] C. Donini, D.N. Robinson, P. Colombo, F. Giordano K. Takada: Biomaterials, 26, 7154–7163 (2005).
and N.A. Peppas: Int. J. Pharm., 245, 83–91 (2002). [47] M.A. Kisel, L.N. Kulik, I.S. Tsybovsky, A.P. Vlasov,
[23] M.T. Lugo, N.A. Peppas: J. Nanopart. Res., 4, 73–81 M.S. Vorob’yov, E.A. Kholodova and Z.V.
(2002). Zabarovskaya: Int. J. Pharm., 216, 105–114 (2001).

449